Cerebral microbleeds as a biomarker in Alzheimer's disease? A review in the field (Q38660991)

5 September 2017

Cerebral microbleeds as a biomarker in Alzheimer's disease? A review in the field (English)

1 reference

5 September 2017

0 references

0 references

Sara Shams

1

0 references

Lars-Olof Wahlund

object named as

Lars-Olof Wahlund

series ordinal

2

0 references

publication date

7 December 2015

1 reference

5 September 2017

Biomarkers in Medicine

1 reference

5 September 2017

10

1 reference

5 September 2017

1

1 reference

5 September 2017

9-18

1 reference

Cerebral microbleeds: histopathological correlation of neuroimaging.

5 September 2017

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Elderly and forgetful with transient neurological spells: a story of two amyloids?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Cerebral amyloid angiopathy in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Cerebral amyloid angiopathy. A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Hypertension and cognitive function: Pathophysiologic effects of hypertension on the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Vascular dementia and Alzheimer's disease - are we in a dead-end road?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Cerebral microbleeds: a guide to detection and interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Cerebral microbleeds on MR imaging: comparison between 1.5 and 7T.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Susceptibility-weighted imaging is more reliable than T2*-weighted gradient-recalled echo MRI for detecting microbleeds

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Clinical relevance of improved microbleed detection by susceptibility-weighted magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Small chronic hemorrhages and ischemic lesions in association with spontaneous intracerebral hematomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Direct comparison of histology of microbleeds with postmortem MR images: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Prevalence and severity of microbleeds in a memory clinic setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Cerebral microbleeds in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Clinical aspects of microbleeds in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Pattern of and risk factors for brain microbleeds in neurodegenerative dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Specific risk factors for microbleeds and white matter hyperintensities in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Prevalence of cortical superficial siderosis in patients with cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Incidence of cerebral microbleeds in preclinical Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Prevalence and topography of small hypointense foci suggesting microbleeds on 3T susceptibility-weighted imaging in various types of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Prevalence and clinical implication of microbleeds in dementia with lewy bodies in comparison with microbleeds in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Subclinical brain hemorrhages in Alzheimer's disease: evaluation by magnetic resonance T2*-weighted images.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Prevalence and clinicoradiological analyses of patients with Alzheimer disease coexisting multiple microbleeds

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Cerebrovascular lesions in elderly Japanese patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Analysis of cerebral lobar microbleeds and a decreased cerebral blood flow in a memory clinic setting

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Microbleeds do not affect rate of cognitive decline in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Brain microbleeds: more evidence, but still a clinical dilemma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Focal hemosiderin deposits and β-amyloid load in the ADNI cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

The significance of cortical cerebellar microbleeds and microinfarcts in neurodegenerative and cerebrovascular diseases. A post-mortem 7.0-tesla magnetic resonance study with neuropathological correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Incidence of cerebral microbleeds: a longitudinal study in a memory clinic population.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic population.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Cerebral microbleeds, retinopathy, and dementia: the AGES-Reykjavik Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Progression of mild cognitive impairment to dementia: contribution of cerebrovascular disease compared with medial temporal lobe atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Multiple or mixed cerebral microbleeds and dementia in patients with vascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Cerebral microhemorrhage and iron deposition in mild cognitive impairment: susceptibility-weighted MR imaging assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically verified Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Spectrum of transient focal neurological episodes in cerebral amyloid angiopathy: multicentre magnetic resonance imaging cohort study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Microbleeds relate to altered amyloid-β metabolism in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Clinical phenotypes of Cerebral Amyloid Angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Cerebral amyloid angiopathy with and without hemorrhage: evidence for different disease phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

In vivo detection of cortical microinfarcts on ultrahigh-field MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Increased number of microinfarcts in Alzheimer disease at 7-T MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Microbleeds in postmortem brains of patients with Alzheimer disease: a T2*-weighted gradient-echo 7.0 T magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Alzheimer disease and risk of stroke: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Aspirin in Alzheimer's disease: increased risk of intracerebral hemorrhage: cause for concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

MR imaging features of amyloid-related imaging abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Pathogenesis of cerebral microbleeds: In vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

No evidence for additional blood-brain barrier P-glycoprotein dysfunction in Alzheimer's disease patients with microbleeds

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

The role of the ATP-binding cassette transporter P-glycoprotein in the transport of β-amyloid across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

The role of P-glycoprotein in cerebral amyloid angiopathy; implications for the early pathogenesis of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Microbleed Topography, Leukoaraiosis, and Cognition in Probable Alzheimer Disease From the Sunnybrook Dementia Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

Comparison of 7.0-T T2*-Magnetic Resonance Imaging of Cerebral Bleeds in Post-Mortem Brain Sections of Alzheimer Patients with Their Neuropathological Correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.15.101

21 January 2018

Identifiers

DOI

10.2217/BMM.15.101

1 reference

5 September 2017

1 reference

PubMed ID

26641942